Cytosorbents Corp — Director's Dealing 2014

Sep 15, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2014-09-11

Reporting Person: Gunton James T. (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-11	Common Stock	S	25000	$0.24	Disposed	1407601	Indirect
2014-09-12	Common Stock	S	5450	$0.24	Disposed	1402151	Indirect

Footnotes

F1: Sales conducted pursuant to a 10b5-1 trading plan effective as of September 9, 2014, as adopted in accordance with rule 10b5-1 of the Securities Exchange Act of 1934, as amended, by NJTC Investment Fund, LP, of which the Reporting Person is a partner.

F2: These securities are held directly by NJTC Investment Fund, LP, of which the Reporting Person is a partner. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, or any other purpose.